Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Debt (2023 - 2025)

Profound Medical (PROF) has 3 years of Non-Current Debt data on record, last reported at $4.5 million in Q4 2025.

  • For Q4 2025, Non-Current Debt rose 53.86% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, up 53.86%, while the annual FY2025 figure was $4.5 million, 53.86% up from the prior year.
  • Non-Current Debt reached $4.5 million in Q4 2025 per PROF's latest filing, up from $4.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $5.0 million in Q4 2023 and bottomed at $2.9 million in Q4 2024.
  • Average Non-Current Debt over 3 years is $4.3 million, with a median of $4.5 million recorded in 2025.
  • Peak YoY movement for Non-Current Debt: tumbled 41.52% in 2024, then skyrocketed 53.86% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $5.0 million in 2023, then crashed by 41.52% to $2.9 million in 2024, then skyrocketed by 53.86% to $4.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $4.5 million in Q4 2025, $4.5 million in Q2 2025, and $4.5 million in Q1 2025.